Nalcrom (Sodium Cromoglicate)

Sodium cromoglicate, the active ingredient in Nalcrom, is a mast cell stabilizer presented as an oral formulation for oral use. It treats allergic conditions such as allergic rhinitis, conjunctivitis, asthma prophylaxis and food allergy, primarily in patients requiring antiallergic therapy.

GNH USA supplies Nalcrom as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑compliant packaging for export to multiple regions. Its global network ensures reliable delivery to healthcare providers across Europe, Asia, Africa and the Americas.

Nalcrom, a mast cell stabilizer, is used to manage allergic disorders by preventing mast cell degranulation.

Allergic rhinitis: reduces nasal congestion, sneezing and itching. Allergic conjunctivitis: alleviates eye itching, redness and watery discharge. Asthma prophylaxis: decreases frequency of bronchospasm episodes and improves airway stability. Food allergy: helps prevent systemic allergic reactions after exposure to trigger foods.

Sodium cromoglicate is generally well tolerated, but some patients may experience adverse reactions.

Common Side Effects: - Taste alteration: mild metallic or bitter taste. - Nausea: occasional stomach upset. - Abdominal discomfort: mild cramps or pain. - Headache: transient. - Diarrhea: loose stools.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate medical attention. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Bronchospasm: paradoxical worsening of breathing in susceptible individuals.

Before initiating Nalcrom, consider the following precautions.

Pregnancy: use only if clearly needed; consult healthcare provider. Breastfeeding: monitor infant for possible effects; discuss with physician. Renal impairment: assess kidney function and adjust therapy if required. Known hypersensitivity: avoid in patients with documented allergy to sodium cromoglicate or related compounds. Concomitant medications: review all drugs for potential interactions, especially other mast cell stabilizers. Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Sodium cromoglicate may interact with other medicines; the following interactions are recognized.

Major Interactions (Avoid): - Concurrent use with other mast cell stabilizers: may increase risk of additive side effects. - Use with high‑dose aspirin or NSAIDs in patients with asthma: may exacerbate bronchospasm.

Moderate Interactions (Monitor Closely): - Antihistamines: combined effect may enhance antiallergic response; monitor symptom control. - Oral corticosteroids: may require dose adjustment of either agent. - Theophylline: possible alteration of plasma levels; monitor therapeutic response. - Beta‑agonists: may reduce the perceived benefit of cromoglicate; assess clinical response.